James Mickleboro | April 10, 2018 3:34pm
More »
Motley Fool Staff | January 15, 2018 5:46pm
More »
James Mickleboro | December 21, 2017 10:20am
More »
About Telix Pharmaceuticals Ltd (ASX: TLX)
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.
Share Price History
Data provided by Morningstar.
Date |
Close |
Change |
% Change |
Volume |
Open |
High |
Low |
24 Feb 2021 |
$3.91 |
$-0.09 |
-2.25% |
603,037 |
$4.00 |
$4.05 |
$3.91 |
23 Feb 2021 |
$4.00 |
$-0.10 |
-2.44% |
613,575 |
$4.07 |
$4.08 |
$3.94 |
22 Feb 2021 |
$4.10 |
$-0.03 |
-0.73% |
695,833 |
$4.12 |
$4.15 |
$4.05 |
19 Feb 2021 |
$4.13 |
$0.00 |
0.00% |
523,224 |
$4.18 |
$4.22 |
$4.13 |
18 Feb 2021 |
$4.13 |
$-0.04 |
-0.96% |
254,991 |
$4.22 |
$4.22 |
$4.12 |
17 Feb 2021 |
$4.17 |
$0.02 |
0.48% |
288,552 |
$4.26 |
$4.26 |
$4.07 |
16 Feb 2021 |
$4.15 |
$0.03 |
0.73% |
381,154 |
$4.15 |
$4.31 |
$4.06 |
15 Feb 2021 |
$4.12 |
$-0.03 |
-0.72% |
825,704 |
$4.24 |
$4.37 |
$4.12 |
12 Feb 2021 |
$4.15 |
$0.05 |
1.22% |
342,456 |
$4.19 |
$4.23 |
$4.15 |
11 Feb 2021 |
$4.10 |
$-0.20 |
-4.65% |
467,247 |
$4.30 |
$4.35 |
$4.06 |
10 Feb 2021 |
$4.30 |
$-0.10 |
-2.27% |
337,374 |
$4.45 |
$4.49 |
$4.28 |
09 Feb 2021 |
$4.40 |
$0.03 |
0.69% |
372,990 |
$4.39 |
$4.47 |
$4.31 |
08 Feb 2021 |
$4.37 |
$0.18 |
4.30% |
548,097 |
$4.20 |
$4.42 |
$4.17 |
05 Feb 2021 |
$4.19 |
$0.23 |
5.81% |
527,308 |
$4.06 |
$4.36 |
$4.04 |
04 Feb 2021 |
$3.96 |
$-0.28 |
-6.60% |
431,625 |
$4.20 |
$4.24 |
$3.96 |
03 Feb 2021 |
$4.24 |
$0.12 |
2.91% |
663,650 |
$4.12 |
$4.25 |
$4.02 |
02 Feb 2021 |
$4.12 |
$0.24 |
6.19% |
481,226 |
$4.02 |
$4.17 |
$3.97 |
01 Feb 2021 |
$3.88 |
$-0.05 |
-1.27% |
1,139,766 |
$3.86 |
$3.95 |
$3.66 |
29 Jan 2021 |
$3.93 |
$-0.10 |
-2.48% |
466,190 |
$4.05 |
$4.16 |
$3.91 |
28 Jan 2021 |
$4.03 |
$-0.27 |
-6.28% |
906,848 |
$4.11 |
$4.14 |
$3.88 |
27 Jan 2021 |
$4.30 |
$-0.06 |
-1.38% |
841,662 |
$4.42 |
$4.42 |
$4.00 |
Show more
Director Transactions
Data provided by Morningstar.
Date |
Director |
Type |
Amount |
Value |
Notes |
02 Nov 2020 |
Oliver Buck |
Exercise |
165 |
$140,530 |
|
02 Nov 2020 |
Oliver Buck |
Buy |
165 |
$140,530 |
|
12 May 2020 |
Christian Behrenbruch |
Issued |
200 |
$294,000 |
|
27 Feb 2020 |
Mark Nelson |
Buy |
400 |
$580,000 |
|
Directors & Management
Data provided by Morningstar.
Name |
Title |
StartDate |
Profile |
Mr Harry Kevin McCann |
Non-Executive Chairman,Non-Executive Director |
Sep 2017 |
|
Ms Jann E Skinner |
Non-Executive Director |
Jun 2018 |
|
Dr Christian Peter Behrenbruch |
Chief Executive Officer,Managing Director |
Jan 2017 |
|
Dr Andreas Kluge |
Executive Director,Chief Medical Officer |
Jan 2017 |
|
Mr Oliver Buck |
Non-Executive Director |
Jan 2017 |
|
Dr Mark Alexander Nelson |
Non-Executive Director |
Sep 2017 |
|
Ms Melanie Farris |
Company Secretary |
Mar 2017 |
|
David Cade |
Chief Business Officer & Head of Investor Relations |
|
|
Melanie Farris |
Company Secretary |
|
|
Ros Wilson |
Global Head of Drug Development |
|
|
Douglas Cubbin |
Group Chief Financial Officer |
|
|
Gabriel Liberatore |
Group Chief Operating Officer |
|
|
Melanie Farris |
Group Secretary & Head of Corporate Governance Chief People Officer |
|
|
Ludovic Wouters |
President, Telix Europe (Interim) |
|
|
Shintaro Nishimura |
President, Telix Japan |
|
|
Bernard Lambert |
President, Telix USA |
|
|
Show more
Top Share Holders
Data provided by Morningstar.
Name |
Shares |
Capital |
HSBC Custody Nominees (Australia) Limited |
32,489,522 |
12.83% |
Elk River Holdings Pty Ltd |
24,675,000 |
9.74% |
Gnosis Verwaltungsgesellschaftm B H |
24,675,000 |
9.74% |
BNP Paribas Noms Pty Ltd |
9,406,521 |
3.71% |
Dale Ltd |
7,995,600 |
3.16% |
J P Morgan Nominees Australia Pty Limited |
7,515,730 |
2.97% |
The Oncidium Foundation |
6,719,898 |
2.65% |
Citicorp Nominees Pty Limited |
4,841,331 |
1.91% |
Uv Cap Gmbh & Co Kg |
4,700,000 |
1.86% |
UBS Nominees Pty Ltd |
4,277,983 |
1.69% |
Jean-Marc Le Doussal |
3,901,554 |
1.54% |
BNP Paribas Nominees Pty Ltd |
3,845,417 |
1.52% |
HSBC Custody Nominees (Australia) Limited A/C 2 |
3,425,710 |
1.35% |
Uv-Cap Gmbh & Co |
3,075,000 |
1.21% |
National Nominees Limited |
2,941,405 |
1.16% |
Remora Capital |
2,613,163 |
1.03% |
Ilusa Sprl |
2,558,138 |
1.01% |
Yelwac Pty Ltd |
2,381,804 |
0.94% |
Cyclotek Pty Ltd |
2,350,000 |
0.93% |
Sargon Ct Pty Ltd |
2,242,500 |
0.89% |
Man Holdings Pty Ltd |
2,238,750 |
0.88% |
Show more